VAERS reports by lot

Pfizer COVID-19 lot PAA173696: VAERS reports

21 VAERS reports list lot PAA173696 as a Pfizer COVID-19 vaccine, received between 2021-09-22 and 2022-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
19%
Marked serious
2
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1219%
Gastrointestinal1117%
Respiratory1016%
Neurological812%
Cardiac / Cardiovascular812%
Dermatological (non-injection-site)58%
Injection-site / Local reaction46%
Musculoskeletal35%
Psychiatric / Neuropsychiatric23%
Allergic / Anaphylactic12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois3
New Jersey2
Indiana2
Pennsylvania2
Michigan1
Washington1
New York1
Ohio1
Texas1
Kentucky1
Arkansas1
Colorado1

Reports by month received

2021-091
2021-106
2021-112
2021-124
2022-013
2022-023
2022-062

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.